We are live on !
Find out more
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
Turnover
60.27%
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$1.42B
(+10%)
Cap. Flow
+$81.1M
Cap. Flow % of AUM
Cap. Flow %
0.52%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407
Avg Time Held
Equity + Options
0.3
years
Top 10 Avg Time Held
Equity + Options
0.2
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$311M |
| 2 |
Abbott
ABT
|
+$125M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$121M |
| 4 |
SpaceX
SPCX
|
+$116M |
| 5 |
Procter & Gamble
PG
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$128M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$111M |
| 3 |
Elastic
ESTC
|
+$110M |
| 4 |
Twilio
TWLO
|
+$110M |
| 5 |
Intuitive Surgical
ISRG
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.5% |
| 2 | Financials | 16.81% |
| 3 | Miscellaneous | 15.64% |
| 4 | Technology | 13.57% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
926
iShares US Real Estate ETF
IYR
$4.11B
| $102 | ﹤0.01% |
+1
| New | +$101 |
2026 Q2
0 quarters
|
|
927
Kenvue
KVUE
$37B
| $96 | ﹤0.01% |
+5
| New | +$88 |
2026 Q2
0 quarters
|
|
928
Gorman-Rupp
GRC
$1.91B
| $92 | ﹤0.01% |
+1
| New | +$76 |
2026 Q2
0 quarters
|
|
929
Charles Schwab
SCHW
$157B
| $92 | ﹤0.01% |
1
-680,817
| -100% | -$62.1M |
2024 Q4
6 quarters
|
|
930
Equitable Holdings
EQH
$14.7B
| $88 | ﹤0.01% |
2
-56,630
| -100% | -$2.37M |
2024 Q4
6 quarters
|
|
931
Helen of Troy
HELE
$688M
| $87 | ﹤0.01% |
3
| – | – |
2026 Q1
1 quarter
|
|
932
NCR Atleos
NATL
$3.44B
| $87 | ﹤0.01% |
2
| – | – |
2026 Q1
1 quarter
|
|
933
1st Source
SRCE
$2.08B
| $82 | ﹤0.01% |
+1
| New | +$75 |
2026 Q2
0 quarters
|
|
934
DELISTED
SkyWater Technology
SKYT
| $70 | ﹤0.01% |
2
| – | – |
2026 Q1
1 quarter
|
|
935
Korn Ferry
KFY
$4.09B
| $67 | ﹤0.01% |
1
-30,973
| -100% | -$2.1M |
2025 Q4
2 quarters
|
|
936
Aktis Oncology
AKTS
$894M
| $64 | ﹤0.01% |
+2
| New | +$41 |
2026 Q2
0 quarters
|
|
937
Beta Bionics
BBNX
$957M
| $63 | ﹤0.01% |
+4
| New | +$48 |
2026 Q2
0 quarters
|
|
938
State Street SPDR S&P Insurance ETF
KIE
$543M
| $61 | ﹤0.01% |
+1
| New | +$57 |
2026 Q2
0 quarters
|
|
939
Centerspace
CSR
$944M
| $56 | ﹤0.01% |
1
| – | – |
2026 Q1
1 quarter
|
|
940
Stepan Co
SCL
$1.44B
| $56 | ﹤0.01% |
1
| – | – |
2026 Q1
1 quarter
|
|
941
State Street Financial Select Sector SPDR ETF
XLF
$51.8B
| $54 | ﹤0.01% |
1
-1
| -50% | -$52 |
2025 Q4
2 quarters
|
|
942
Cable One
CABO
$35.2M
| $53 | ﹤0.01% |
1
| – | – |
2026 Q1
1 quarter
|
|
943
DELISTED
Janus Henderson
JHG
| $52 | ﹤0.01% |
1
| – | – |
2026 Q1
1 quarter
|
|
944
Enviri
NVRI
$562M
| $44 | ﹤0.01% |
+2
| New | +$40 |
2026 Q2
0 quarters
|
|
945
Cannae Holdings
CNNE
$700M
| $43 | ﹤0.01% |
3
| – | – |
2026 Q1
1 quarter
|
|
946
Dime Commercial Bancshares
DCOM
$1.81B
| $41 | ﹤0.01% |
1
-1
| -50% | -$37 |
2026 Q1
1 quarter
|
|
947
Orrstown Financial Services
ORRF
$828M
| $41 | ﹤0.01% |
1
| – | – |
2026 Q1
1 quarter
|
|
948
Once Upon a Farm PBC
OFRM
$722M
| $41 | ﹤0.01% |
+2
| New | +$33 |
2026 Q2
0 quarters
|
|
949
Ladder Capital
LADR
$1.15B
| $40 | ﹤0.01% |
+4
| New | +$41 |
2026 Q2
0 quarters
|
|
950
DELISTED
Stellar Bancorp
STEL
| $39 | ﹤0.01% |
+1
| New | +$38 |
2026 Q2
0 quarters
|
|
Similar funds
Freestone Grove Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.
- Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
- Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
- Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
- Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
- Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
- Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
- Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.